Ikarian Capital, LLC - GEMINI THERAPEUTICS INC ownership

GEMINI THERAPEUTICS INC's ticker is GMTX and the CUSIP is 36870G105. A total of 46 filers reported holding GEMINI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of GEMINI THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$749,000
+21.8%
443,0960.0%0.14%
+69.1%
Q1 2022$615,000
-49.8%
443,096
+5.2%
0.08%
-55.5%
Q4 2021$1,225,000
-28.0%
421,0500.0%0.18%
+51.7%
Q3 2021$1,701,000
-38.3%
421,050
-1.3%
0.12%
-46.2%
Q2 2021$2,759,000
-70.2%
426,455
-37.7%
0.22%
-28.5%
Q1 2021$9,273,000684,3790.31%
Other shareholders
GEMINI THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 2,435,125$9,838,0003.06%
Asymmetry Capital Management, L.P. 284,079$1,148,0000.69%
Orbimed Advisors 5,826,224$23,538,0000.26%
Boxer Capital, LLC 1,300,000$5,252,0000.18%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,137,823$8,637,0000.15%
Ikarian Capital, LLC 421,050$1,701,0000.12%
JS Capital Management LLC 474,457$1,917,0000.11%
PURA VIDA INVESTMENTS, LLC 494,400$1,997,0000.06%
HARVARD MANAGEMENT CO INC 250,000$1,010,0000.06%
Atom Investors LP 102,792$415,0000.03%
View complete list of GEMINI THERAPEUTICS INC shareholders